RA Capital Management - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
RA Capital Management ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$420,800,369
-2.7%
6,264,7070.0%8.28%
+1.5%
Q2 2023$432,452,724
+268.1%
6,264,707
+157.1%
8.16%
+207.1%
Q1 2023$117,474,673
-3.4%
2,436,2230.0%2.66%
+7.8%
Q4 2022$121,616,252
+27.5%
2,436,223
+4.2%
2.47%
+21.2%
Q3 2022$95,415,000
+137.8%
2,338,610
+139.2%
2.04%
+216.1%
Q2 2021$40,126,000
-40.8%
977,503
-59.4%
0.64%
-32.1%
Q4 2020$67,818,000
-8.8%
2,408,2920.0%0.95%
-30.3%
Q3 2020$74,344,000
-29.6%
2,408,292
-3.0%
1.36%
-33.9%
Q2 2020$105,631,0002,481,9422.06%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2023
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 526,072$21,595,00011.36%
Consonance Capital Management LP 1,647,497$67,630,0008.14%
Johnson & Johnson Innovation - JJDC, Inc. 1,629,173$66,878,0006.84%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,342,442$55,107,0002.29%
Vivo Capital, LLC 956,702$39,273,0001.70%
Hudson Bay Capital Management LP 1,878,374$77,107,0000.93%
Capital International Sarl 220,470$9,050,0000.78%
Capital International, Inc./CA/ 1,951,845$80,123,0000.72%
Avidity Partners Management LP 625,000$25,656,0000.69%
INDUS CAPITAL PARTNERS, LLC 94,678$3,887,0000.66%
View complete list of LEGEND BIOTECH CORP shareholders